Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Kidney Cancer Drugs market report explains the definition, types, applications, major countries, and major players of the Kidney Cancer Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Abbott Laboratories
Novartis
AVEO Pharmaceuticals
Bristol-Myers Squibb
Cerulean Pharma
Immunicum
ArQule
Onyx Therapeutics
Wilex
Amgen
Ono Pharmaceutical
immatics biotechnologies
Pfizer
Bayer
GlaxoSmithKline
Tracon Pharmaceuticals
Prometheus Laboratories
Genentech
Active Biotech
Roche
Oxford BioMedica
Taiwan Liposome
Argos Therapeutics
Exelixis
Bionomics
Seattle Genetics
By Type:
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
By End-User:
Renal cell carcinoma (RCC)
Transitional cell carcinoma (TCC)
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Kidney Cancer Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Kidney Cancer Drugs Outlook to 2028- Original Forecasts
-
2.2 Kidney Cancer Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Kidney Cancer Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Kidney Cancer Drugs Market- Recent Developments
-
6.1 Kidney Cancer Drugs Market News and Developments
-
6.2 Kidney Cancer Drugs Market Deals Landscape
7 Kidney Cancer Drugs Raw Materials and Cost Structure Analysis
-
7.1 Kidney Cancer Drugs Key Raw Materials
-
7.2 Kidney Cancer Drugs Price Trend of Key Raw Materials
-
7.3 Kidney Cancer Drugs Key Suppliers of Raw Materials
-
7.4 Kidney Cancer Drugs Market Concentration Rate of Raw Materials
-
7.5 Kidney Cancer Drugs Cost Structure Analysis
-
7.5.1 Kidney Cancer Drugs Raw Materials Analysis
-
7.5.2 Kidney Cancer Drugs Labor Cost Analysis
-
7.5.3 Kidney Cancer Drugs Manufacturing Expenses Analysis
8 Global Kidney Cancer Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Kidney Cancer Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Kidney Cancer Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Kidney Cancer Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Kidney Cancer Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global mTOR Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cytokine Immunotherapy (IL-2) Consumption and Growth Rate (2017-2022)
-
9.2 Global Kidney Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Renal cell carcinoma (RCC) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Transitional cell carcinoma (TCC) Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Kidney Cancer Drugs Market Analysis and Outlook till 2022
-
10.1 Global Kidney Cancer Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Kidney Cancer Drugs Consumption (2017-2022)
-
10.2.2 Canada Kidney Cancer Drugs Consumption (2017-2022)
-
10.2.3 Mexico Kidney Cancer Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Kidney Cancer Drugs Consumption (2017-2022)
-
10.3.2 UK Kidney Cancer Drugs Consumption (2017-2022)
-
10.3.3 Spain Kidney Cancer Drugs Consumption (2017-2022)
-
10.3.4 Belgium Kidney Cancer Drugs Consumption (2017-2022)
-
10.3.5 France Kidney Cancer Drugs Consumption (2017-2022)
-
10.3.6 Italy Kidney Cancer Drugs Consumption (2017-2022)
-
10.3.7 Denmark Kidney Cancer Drugs Consumption (2017-2022)
-
10.3.8 Finland Kidney Cancer Drugs Consumption (2017-2022)
-
10.3.9 Norway Kidney Cancer Drugs Consumption (2017-2022)
-
10.3.10 Sweden Kidney Cancer Drugs Consumption (2017-2022)
-
10.3.11 Poland Kidney Cancer Drugs Consumption (2017-2022)
-
10.3.12 Russia Kidney Cancer Drugs Consumption (2017-2022)
-
10.3.13 Turkey Kidney Cancer Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Kidney Cancer Drugs Consumption (2017-2022)
-
10.4.2 Japan Kidney Cancer Drugs Consumption (2017-2022)
-
10.4.3 India Kidney Cancer Drugs Consumption (2017-2022)
-
10.4.4 South Korea Kidney Cancer Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Kidney Cancer Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Kidney Cancer Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Kidney Cancer Drugs Consumption (2017-2022)
-
10.4.8 Thailand Kidney Cancer Drugs Consumption (2017-2022)
-
10.4.9 Singapore Kidney Cancer Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Kidney Cancer Drugs Consumption (2017-2022)
-
10.4.11 Philippines Kidney Cancer Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Kidney Cancer Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Kidney Cancer Drugs Consumption (2017-2022)
-
10.5.2 Colombia Kidney Cancer Drugs Consumption (2017-2022)
-
10.5.3 Chile Kidney Cancer Drugs Consumption (2017-2022)
-
10.5.4 Argentina Kidney Cancer Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Kidney Cancer Drugs Consumption (2017-2022)
-
10.5.6 Peru Kidney Cancer Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Kidney Cancer Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Kidney Cancer Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Kidney Cancer Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Kidney Cancer Drugs Consumption (2017-2022)
-
10.6.3 Oman Kidney Cancer Drugs Consumption (2017-2022)
-
10.6.4 Qatar Kidney Cancer Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Kidney Cancer Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Kidney Cancer Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Kidney Cancer Drugs Consumption (2017-2022)
-
10.7.2 South Africa Kidney Cancer Drugs Consumption (2017-2022)
-
10.7.3 Egypt Kidney Cancer Drugs Consumption (2017-2022)
-
10.7.4 Algeria Kidney Cancer Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Kidney Cancer Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Kidney Cancer Drugs Consumption (2017-2022)
11 Global Kidney Cancer Drugs Competitive Analysis
-
11.1 Abbott Laboratories
-
11.1.1 Abbott Laboratories Company Details
-
11.1.2 Abbott Laboratories Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Abbott Laboratories Kidney Cancer Drugs Main Business and Markets Served
-
11.1.4 Abbott Laboratories Kidney Cancer Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Novartis
-
11.2.1 Novartis Company Details
-
11.2.2 Novartis Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Novartis Kidney Cancer Drugs Main Business and Markets Served
-
11.2.4 Novartis Kidney Cancer Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 AVEO Pharmaceuticals
-
11.3.1 AVEO Pharmaceuticals Company Details
-
11.3.2 AVEO Pharmaceuticals Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 AVEO Pharmaceuticals Kidney Cancer Drugs Main Business and Markets Served
-
11.3.4 AVEO Pharmaceuticals Kidney Cancer Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Bristol-Myers Squibb
-
11.4.1 Bristol-Myers Squibb Company Details
-
11.4.2 Bristol-Myers Squibb Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Bristol-Myers Squibb Kidney Cancer Drugs Main Business and Markets Served
-
11.4.4 Bristol-Myers Squibb Kidney Cancer Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Cerulean Pharma
-
11.5.1 Cerulean Pharma Company Details
-
11.5.2 Cerulean Pharma Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Cerulean Pharma Kidney Cancer Drugs Main Business and Markets Served
-
11.5.4 Cerulean Pharma Kidney Cancer Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Immunicum
-
11.6.1 Immunicum Company Details
-
11.6.2 Immunicum Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Immunicum Kidney Cancer Drugs Main Business and Markets Served
-
11.6.4 Immunicum Kidney Cancer Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 ArQule
-
11.7.1 ArQule Company Details
-
11.7.2 ArQule Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 ArQule Kidney Cancer Drugs Main Business and Markets Served
-
11.7.4 ArQule Kidney Cancer Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Onyx Therapeutics
-
11.8.1 Onyx Therapeutics Company Details
-
11.8.2 Onyx Therapeutics Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Onyx Therapeutics Kidney Cancer Drugs Main Business and Markets Served
-
11.8.4 Onyx Therapeutics Kidney Cancer Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Wilex
-
11.9.1 Wilex Company Details
-
11.9.2 Wilex Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Wilex Kidney Cancer Drugs Main Business and Markets Served
-
11.9.4 Wilex Kidney Cancer Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Amgen
-
11.10.1 Amgen Company Details
-
11.10.2 Amgen Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Amgen Kidney Cancer Drugs Main Business and Markets Served
-
11.10.4 Amgen Kidney Cancer Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Ono Pharmaceutical
-
11.11.1 Ono Pharmaceutical Company Details
-
11.11.2 Ono Pharmaceutical Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Ono Pharmaceutical Kidney Cancer Drugs Main Business and Markets Served
-
11.11.4 Ono Pharmaceutical Kidney Cancer Drugs Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 immatics biotechnologies
-
11.12.1 immatics biotechnologies Company Details
-
11.12.2 immatics biotechnologies Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 immatics biotechnologies Kidney Cancer Drugs Main Business and Markets Served
-
11.12.4 immatics biotechnologies Kidney Cancer Drugs Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Pfizer
-
11.13.1 Pfizer Company Details
-
11.13.2 Pfizer Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Pfizer Kidney Cancer Drugs Main Business and Markets Served
-
11.13.4 Pfizer Kidney Cancer Drugs Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Bayer
-
11.14.1 Bayer Company Details
-
11.14.2 Bayer Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Bayer Kidney Cancer Drugs Main Business and Markets Served
-
11.14.4 Bayer Kidney Cancer Drugs Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 GlaxoSmithKline
-
11.15.1 GlaxoSmithKline Company Details
-
11.15.2 GlaxoSmithKline Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 GlaxoSmithKline Kidney Cancer Drugs Main Business and Markets Served
-
11.15.4 GlaxoSmithKline Kidney Cancer Drugs Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Tracon Pharmaceuticals
-
11.16.1 Tracon Pharmaceuticals Company Details
-
11.16.2 Tracon Pharmaceuticals Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Tracon Pharmaceuticals Kidney Cancer Drugs Main Business and Markets Served
-
11.16.4 Tracon Pharmaceuticals Kidney Cancer Drugs Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Prometheus Laboratories
-
11.17.1 Prometheus Laboratories Company Details
-
11.17.2 Prometheus Laboratories Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Prometheus Laboratories Kidney Cancer Drugs Main Business and Markets Served
-
11.17.4 Prometheus Laboratories Kidney Cancer Drugs Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Genentech
-
11.18.1 Genentech Company Details
-
11.18.2 Genentech Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Genentech Kidney Cancer Drugs Main Business and Markets Served
-
11.18.4 Genentech Kidney Cancer Drugs Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Active Biotech
-
11.19.1 Active Biotech Company Details
-
11.19.2 Active Biotech Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Active Biotech Kidney Cancer Drugs Main Business and Markets Served
-
11.19.4 Active Biotech Kidney Cancer Drugs Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Roche
-
11.20.1 Roche Company Details
-
11.20.2 Roche Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Roche Kidney Cancer Drugs Main Business and Markets Served
-
11.20.4 Roche Kidney Cancer Drugs Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Oxford BioMedica
-
11.21.1 Oxford BioMedica Company Details
-
11.21.2 Oxford BioMedica Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Oxford BioMedica Kidney Cancer Drugs Main Business and Markets Served
-
11.21.4 Oxford BioMedica Kidney Cancer Drugs Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Taiwan Liposome
-
11.22.1 Taiwan Liposome Company Details
-
11.22.2 Taiwan Liposome Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Taiwan Liposome Kidney Cancer Drugs Main Business and Markets Served
-
11.22.4 Taiwan Liposome Kidney Cancer Drugs Product Portfolio
-
11.22.5 Recent Research and Development Strategies
-
11.23 Argos Therapeutics
-
11.23.1 Argos Therapeutics Company Details
-
11.23.2 Argos Therapeutics Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.23.3 Argos Therapeutics Kidney Cancer Drugs Main Business and Markets Served
-
11.23.4 Argos Therapeutics Kidney Cancer Drugs Product Portfolio
-
11.23.5 Recent Research and Development Strategies
-
11.24 Exelixis
-
11.24.1 Exelixis Company Details
-
11.24.2 Exelixis Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.24.3 Exelixis Kidney Cancer Drugs Main Business and Markets Served
-
11.24.4 Exelixis Kidney Cancer Drugs Product Portfolio
-
11.24.5 Recent Research and Development Strategies
-
11.25 Bionomics
-
11.25.1 Bionomics Company Details
-
11.25.2 Bionomics Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.25.3 Bionomics Kidney Cancer Drugs Main Business and Markets Served
-
11.25.4 Bionomics Kidney Cancer Drugs Product Portfolio
-
11.25.5 Recent Research and Development Strategies
-
11.26 Seattle Genetics
-
11.26.1 Seattle Genetics Company Details
-
11.26.2 Seattle Genetics Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.26.3 Seattle Genetics Kidney Cancer Drugs Main Business and Markets Served
-
11.26.4 Seattle Genetics Kidney Cancer Drugs Product Portfolio
-
11.26.5 Recent Research and Development Strategies
12 Global Kidney Cancer Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Kidney Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global mTOR Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Cytokine Immunotherapy (IL-2) Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Kidney Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Renal cell carcinoma (RCC) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Transitional cell carcinoma (TCC) Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Kidney Cancer Drugs Market Analysis and Outlook to 2028
-
13.1 Global Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Kidney Cancer Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Kidney Cancer Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Kidney Cancer Drugs
-
Figure of Kidney Cancer Drugs Picture
-
Table Global Kidney Cancer Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Kidney Cancer Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global mTOR Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Cytokine Immunotherapy (IL-2) Consumption and Growth Rate (2017-2022)
-
Figure Global Renal cell carcinoma (RCC) Consumption and Growth Rate (2017-2022)
-
Figure Global Transitional cell carcinoma (TCC) Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Cancer Drugs Consumption by Country (2017-2022)
-
Table North America Kidney Cancer Drugs Consumption by Country (2017-2022)
-
Figure United States Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Kidney Cancer Drugs Consumption by Country (2017-2022)
-
Figure Germany Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Kidney Cancer Drugs Consumption by Country (2017-2022)
-
Figure China Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Kidney Cancer Drugs Consumption by Country (2017-2022)
-
Figure Brazil Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Kidney Cancer Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Kidney Cancer Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Kidney Cancer Drugs Consumption by Country (2017-2022)
-
Figure Australia Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Kidney Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table Abbott Laboratories Company Details
-
Table Abbott Laboratories Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Kidney Cancer Drugs Main Business and Markets Served
-
Table Abbott Laboratories Kidney Cancer Drugs Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Kidney Cancer Drugs Main Business and Markets Served
-
Table Novartis Kidney Cancer Drugs Product Portfolio
-
Table AVEO Pharmaceuticals Company Details
-
Table AVEO Pharmaceuticals Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AVEO Pharmaceuticals Kidney Cancer Drugs Main Business and Markets Served
-
Table AVEO Pharmaceuticals Kidney Cancer Drugs Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Kidney Cancer Drugs Main Business and Markets Served
-
Table Bristol-Myers Squibb Kidney Cancer Drugs Product Portfolio
-
Table Cerulean Pharma Company Details
-
Table Cerulean Pharma Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cerulean Pharma Kidney Cancer Drugs Main Business and Markets Served
-
Table Cerulean Pharma Kidney Cancer Drugs Product Portfolio
-
Table Immunicum Company Details
-
Table Immunicum Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immunicum Kidney Cancer Drugs Main Business and Markets Served
-
Table Immunicum Kidney Cancer Drugs Product Portfolio
-
Table ArQule Company Details
-
Table ArQule Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table ArQule Kidney Cancer Drugs Main Business and Markets Served
-
Table ArQule Kidney Cancer Drugs Product Portfolio
-
Table Onyx Therapeutics Company Details
-
Table Onyx Therapeutics Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Onyx Therapeutics Kidney Cancer Drugs Main Business and Markets Served
-
Table Onyx Therapeutics Kidney Cancer Drugs Product Portfolio
-
Table Wilex Company Details
-
Table Wilex Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wilex Kidney Cancer Drugs Main Business and Markets Served
-
Table Wilex Kidney Cancer Drugs Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Kidney Cancer Drugs Main Business and Markets Served
-
Table Amgen Kidney Cancer Drugs Product Portfolio
-
Table Ono Pharmaceutical Company Details
-
Table Ono Pharmaceutical Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ono Pharmaceutical Kidney Cancer Drugs Main Business and Markets Served
-
Table Ono Pharmaceutical Kidney Cancer Drugs Product Portfolio
-
Table immatics biotechnologies Company Details
-
Table immatics biotechnologies Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table immatics biotechnologies Kidney Cancer Drugs Main Business and Markets Served
-
Table immatics biotechnologies Kidney Cancer Drugs Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Kidney Cancer Drugs Main Business and Markets Served
-
Table Pfizer Kidney Cancer Drugs Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Kidney Cancer Drugs Main Business and Markets Served
-
Table Bayer Kidney Cancer Drugs Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Kidney Cancer Drugs Main Business and Markets Served
-
Table GlaxoSmithKline Kidney Cancer Drugs Product Portfolio
-
Table Tracon Pharmaceuticals Company Details
-
Table Tracon Pharmaceuticals Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tracon Pharmaceuticals Kidney Cancer Drugs Main Business and Markets Served
-
Table Tracon Pharmaceuticals Kidney Cancer Drugs Product Portfolio
-
Table Prometheus Laboratories Company Details
-
Table Prometheus Laboratories Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prometheus Laboratories Kidney Cancer Drugs Main Business and Markets Served
-
Table Prometheus Laboratories Kidney Cancer Drugs Product Portfolio
-
Table Genentech Company Details
-
Table Genentech Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Kidney Cancer Drugs Main Business and Markets Served
-
Table Genentech Kidney Cancer Drugs Product Portfolio
-
Table Active Biotech Company Details
-
Table Active Biotech Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Active Biotech Kidney Cancer Drugs Main Business and Markets Served
-
Table Active Biotech Kidney Cancer Drugs Product Portfolio
-
Table Roche Company Details
-
Table Roche Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Kidney Cancer Drugs Main Business and Markets Served
-
Table Roche Kidney Cancer Drugs Product Portfolio
-
Table Oxford BioMedica Company Details
-
Table Oxford BioMedica Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oxford BioMedica Kidney Cancer Drugs Main Business and Markets Served
-
Table Oxford BioMedica Kidney Cancer Drugs Product Portfolio
-
Table Taiwan Liposome Company Details
-
Table Taiwan Liposome Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Taiwan Liposome Kidney Cancer Drugs Main Business and Markets Served
-
Table Taiwan Liposome Kidney Cancer Drugs Product Portfolio
-
Table Argos Therapeutics Company Details
-
Table Argos Therapeutics Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Argos Therapeutics Kidney Cancer Drugs Main Business and Markets Served
-
Table Argos Therapeutics Kidney Cancer Drugs Product Portfolio
-
Table Exelixis Company Details
-
Table Exelixis Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Exelixis Kidney Cancer Drugs Main Business and Markets Served
-
Table Exelixis Kidney Cancer Drugs Product Portfolio
-
Table Bionomics Company Details
-
Table Bionomics Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bionomics Kidney Cancer Drugs Main Business and Markets Served
-
Table Bionomics Kidney Cancer Drugs Product Portfolio
-
Table Seattle Genetics Company Details
-
Table Seattle Genetics Kidney Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Kidney Cancer Drugs Main Business and Markets Served
-
Table Seattle Genetics Kidney Cancer Drugs Product Portfolio
-
Figure Global Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global mTOR Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cytokine Immunotherapy (IL-2) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renal cell carcinoma (RCC) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Transitional cell carcinoma (TCC) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Kidney Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Kidney Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Kidney Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Kidney Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Kidney Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Kidney Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Kidney Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Kidney Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
